Curis Inc (CRIS)
14.50
-0.02
(-0.14%)
USD |
NASDAQ |
Apr 26, 15:32
Curis Cash from Investing (TTM): 37.79M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 37.79M |
September 30, 2023 | 26.73M |
June 30, 2023 | 30.86M |
March 31, 2023 | 62.35M |
December 31, 2022 | 33.02M |
September 30, 2022 | 26.04M |
June 30, 2022 | 10.20M |
March 31, 2022 | -46.91M |
December 31, 2021 | -47.90M |
September 30, 2021 | -97.84M |
June 30, 2021 | -86.47M |
March 31, 2021 | -57.96M |
December 31, 2020 | -49.05M |
September 30, 2020 | 5.97M |
June 30, 2020 | 7.585M |
March 31, 2020 | -0.215M |
December 31, 2019 | -4.456M |
September 30, 2019 | -1.351M |
June 30, 2019 | 1.875M |
March 31, 2019 | 23.75M |
December 31, 2018 | 21.37M |
September 30, 2018 | 14.15M |
June 30, 2018 | 14.40M |
March 31, 2018 | -5.421M |
December 31, 2017 | -3.63M |
Date | Value |
---|---|
September 30, 2017 | 13.00M |
June 30, 2017 | 28.29M |
March 31, 2017 | 39.43M |
December 31, 2016 | 30.12M |
September 30, 2016 | 31.72M |
June 30, 2016 | 14.26M |
March 31, 2016 | 24.86M |
December 31, 2015 | -6.428M |
September 30, 2015 | -16.84M |
June 30, 2015 | -18.92M |
March 31, 2015 | -27.75M |
December 31, 2014 | 16.27M |
September 30, 2014 | 5.091M |
June 30, 2014 | -1.646M |
March 31, 2014 | -11.44M |
December 31, 2013 | -13.62M |
September 30, 2013 | -19.43M |
June 30, 2013 | -14.73M |
March 31, 2013 | -14.09M |
December 31, 2012 | -23.00M |
September 30, 2012 | -17.32M |
June 30, 2012 | -6.626M |
March 31, 2012 | -5.189M |
December 31, 2011 | 9.776M |
September 30, 2011 | 15.59M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-97.84M
Minimum
Sep 2021
62.35M
Maximum
Mar 2023
-7.880M
Average
1.875M
Median
Jun 2019
Cash from Investing (TTM) Benchmarks
Kura Oncology Inc | 15.56M |
AIM ImmunoTech Inc | -0.832M |
Perspective Therapeutics Inc | 24.37M |
Protalix BioTherapeutics Inc | -16.71M |
Armata Pharmaceuticals Inc | -8.134M |